Posted in | News | Business | Chemistry

DOE Funding Supports Oxygen Transport Membrane Development by Praxair

Praxair, Inc. (NYSE:PX) has been awarded $35 million by the U.S. Department of Energy (DOE) to accelerate development of oxygen transport membrane (OTM) systems which can dramatically reduce the cost of oxygen for synthesis gas (syngas) production and oxy-fuel combustion.

Building on the success of work previously supported by the DOE to develop basic materials, membrane structures and process integration strategies, this grant will fund OTM equipment and systems development. Pilot-scale combustion and syngas units will be built to demonstrate performance and provide critical data for design of commercial-scale facilities.

Praxair’s OTM technology forms the basis for a zero-emissions, advanced power cycle capable of meeting long-term DOE electricity cost targets for coal-based power plants with carbon dioxide capture. In addition, combustion applications in manufacturing and process plants that may be required to control carbon dioxide emissions would also benefit from commercialization of OTM. OTM syngas systems efficiently convert natural gas and other hydrocarbons to mixtures of hydrogen and carbon monoxide used for making chemicals and liquid fuels.

Praxair is a recognized leader in oxygen-based combustion, with over 200 patents on relevant technologies. Many of these technologies have been in use for decades by customers in the metals, glass, cement and other energy-intensive industries, resulting in reduced emissions, maximized productivity and increased efficiency.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.